Zoligratinib
[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone
Molecular Identity
Zoligratinib
[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone
PubChem CID: 66555680
2D Structure
Properties
C20H16N6O
Molecular Formula
356.40
Molecular Weight
g/mol
356.1386
Exact Mass
Da
3.9
XLogP
Drug-like (Lipinski: < 5)
105
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
4
H-Bond Acceptors
573
Complexity
SMILES
Canonical SMILES
SMILES: CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=CC=CC=C5N4)NIsomeric SMILES
SMILES: CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=CC=CC=C5N4)NSynonyms(20)
1265229-25-1Debio-1347CH5183284zoligratinibCH-5183284Debio 1347NR9ZYH80Z8Fgfr inhibitor debio 1347DEBIO1347[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanoneMethanone, (5-amino-1-(2-methyl-1H-benzimidazol-6-yl)-1H-pyrazol-4-yl)-1H-indol-2-yl-(5-AMINO-1-(2-METHYL-3H-BENZIMIDAZOL-5-YL)PYRAZOL-4-YL)-(1H-INDOL-2-YL)METHANONEFF284Debiopharm 1347RefChem:196223
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Zoligratinib
Loading drug network...